|
CBX4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.771800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.139160E-01 |
| Normal-vs-Stage2 |
1.262220E-01 |
| Normal-vs-Stage3 |
6.782800E-01 |
| Normal-vs-Stage4 |
7.440000E-01 |
| Stage1-vs-Stage2 |
8.666400E-01 |
| Stage1-vs-Stage3 |
1.956010E-04 |
| Stage1-vs-Stage4 |
2.608600E-01 |
| Stage2-vs-Stage3 |
7.401300E-03 |
| Stage2-vs-Stage4 |
2.522000E-01 |
| Stage3-vs-Stage4 |
9.266600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.518400E-01 |
| Normal-vs-AfricanAmerican |
1.865030E-01 |
| Normal-vs-Asian |
4.347400E-01 |
| Caucasian-vs-AfricanAmerican |
6.046600E-01 |
| Caucasian-vs-Asian |
2.046400E-02 |
| AfricanAmerican-vs-Asian |
9.756200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.025000E-01 |
| Normal-vs-Female |
6.138200E-01 |
| Male-vs-Female |
1.335180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.120400E-01 |
| Normal-vs-Extreme_Weight |
2.389000E-01 |
| Normal-vs-Obese |
2.984600E-01 |
| Normal-vs-Extreme_Obese |
4.287000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.681200E-01 |
| Normal_Weight-vs-Obese |
6.198400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.702000E-01 |
| Extreme_Weight-vs-Obese |
7.764000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.267600E-01 |
| Obese-vs-Extreme_Obese |
7.307800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.930000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.917610E-01 |
| Normal-vs-Age(61-80Yrs) |
2.316000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.185980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.282870E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.418400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.855300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.513400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.928000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.540000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.369380E-01 |
| Normal-VS-Type2 PRCC |
3.400200E-01 |
| Normal-VS-KIRP CIMP |
1.325780E-02 |
| Normal-VS-Unclassified PRCC |
2.184000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.450800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.138260E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.254000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.29639999974552E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.984400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.51989999994807E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.265800E-02 |
| Normal-vs-N1 |
2.976600E-01 |
| Normal-vs-N2 |
1.702420E-01 |
| N0-vs-N1 |
5.847600E-04 |
| N0-vs-N2 |
1.758210E-01 |
| N1-vs-N2 |
2.660000E-01 |
|
|
